Wells Fargo’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92K | Sell |
6,825
-20,853
| -75% | -$24.2K | ﹤0.01% | 5548 |
|
|
2025
Q1 | $30.4K | Buy |
27,678
+1,559
| +6% | +$1.72K | ﹤0.01% | 5110 |
|
|
2024
Q4 | $44.9K | Buy |
26,119
+4,861
| +23% | +$8.36K | ﹤0.01% | 5031 |
|
|
2024
Q3 | $52.7K | Buy |
21,258
+827
| +4% | +$2.05K | ﹤0.01% | 4927 |
|
|
2024
Q2 | $49.4K | Buy |
20,431
+19,223
| +1,591% | +$46.5K | ﹤0.01% | 4926 |
|
|
2024
Q1 | $4.89K | Sell |
1,208
-997
| -45% | -$4.04K | ﹤0.01% | 5501 |
|
|
2023
Q4 | $8.47K | Buy |
2,205
+2,011
| +1,037% | +$7.72K | ﹤0.01% | 5433 |
|
|
2023
Q3 | $805 | Sell |
194
-1,907
| -91% | -$7.91K | ﹤0.01% | 5872 |
|
|
2023
Q2 | $10.1K | Sell |
2,101
-995
| -32% | -$4.79K | ﹤0.01% | 5594 |
|
|
2023
Q1 | $12.6K | Buy |
3,096
+1,303
| +73% | +$5.29K | ﹤0.01% | 5467 |
|
|
2022
Q4 | $9.68K | Sell |
1,793
-297
| -14% | -$1.6K | ﹤0.01% | 5244 |
|
|
2022
Q3 | $21K | Buy |
2,090
+1,520
| +267% | +$15.3K | ﹤0.01% | 5037 |
|
|
2022
Q2 | $2K | Sell |
570
-2,203
| -79% | -$7.73K | ﹤0.01% | 5980 |
|
|
2022
Q1 | $11K | Buy |
2,773
+698
| +34% | +$2.77K | ﹤0.01% | 5872 |
|
|
2021
Q4 | $14K | Buy |
2,075
+2,024
| +3,969% | +$13.7K | ﹤0.01% | 5905 |
|
|
2021
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 6304 |
|